Kingmed Diagnostics | Briefing, News, Analysis, Research, Data

Kingmed Diagnostics

Kingmed Diagnostics is a third-party medical inspection service provider.

Kingmed Diagnostics, established in 1994, is a third-party medical inspection and pathological diagnosis service provider, mainly engaging in third-party medical assessment and pathological diagnosis business and providing leading medical diagnosis information integration services and and pathological diagnosis outsourcing services for medical institutions at all levels across the country. Founded by Guangzhou Medical University, it went public in September 2017. Its main shareholder is Liang Yaoming, and peer companies are Transtek Medical Electronics and Inkon Life Technology.

Sector

Healthcare

Industry

Healthcare Services

Sub-industry

Healthcare Services

Founded

May 26, 2006

HQ location

Guangdong, China

Legal name

Guangzhou Kingmed Diagnostics Group Co.,Ltd.

Website

http://www.kingmed.com.cn

sid@kingmed.com.cn

Employees

5001-10000

All
News
Analysis
Research

Briefing Jun 24, 2022 11:15 AM · Healthcare

F-star to be acquired by China biopharmaceutical with USD 161million

Briefing Jun 24, 2022 11:07 AM · Healthcare

"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange

In-depth

Healthcare

Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis

‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’

Jan 30, 2023 02:13 PM

Briefing Jun 24, 2022 10:59 AM · Technology | Healthcare

Herui gene launched the early screening product "quansining" for multiple cancer types, covering six high-risk cancer types

Briefing Jun 24, 2022 10:46 AM · Healthcare

East China medicine "liraglutide" goes to sea

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare, Technology, Consumer Staples

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Briefing Jun 23, 2022 06:25 PM · Healthcare

Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care

Briefing Jun 23, 2022 06:24 PM · Healthcare

Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing

Briefing Jun 23, 2022 10:36 AM · Healthcare

Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China

Briefing Apr 26, 2022 07:05 PM · Healthcare | Industrials

Ningxia building materials: net profit in the first quarter increased by 741% year-on-year

Healthcare

Lanja has completed the Series A funding of hundred millions CNY

Shanghai Lanja Medical Technology Co., Ltd (“Lanja”) recently has announced the completion of the Series A funding of hundred millions CNY.

Sep 11, 2023 10:04 PM

Healthcare

RabPharma has completed the Series A+ funding of hundred millions CNY

Zhongshan RabPharma Biopharmaceutical Co., Ltd. (“RabPharma”) recently has announced the completion of the Series A+ funding of hundred millions CNY.

Sep 05, 2023 10:17 AM

Briefing Jan 12, 2022 08:29 PM · Technology | Healthcare | Financials

10 billion private equity Xitai investment's products suffered a large loss and hit the early warning line

Briefing Jan 12, 2022 12:18 PM · Healthcare

Jinyu medicine: we are actively cooperating in the investigation of Jinyu incident in Zhengzhou

Briefing Dec 18, 2021 03:39 PM · Consumer Staples | Healthcare

Zhong Nanshan: Omicron made many countries understand that China's prevention and control is right

Healthcare

Powertight has completed a pre-Series A funding of hundred millions CNY

Powertight Biotechnology (Hangzhou) Co., Ltd. (“Powertight”) recently has announced the completion of a pre-Series A funding of hundred millions CNY.

Sep 04, 2023 11:43 AM

Healthcare

Foremed Legend has completed the pre-Series A+ funding

Suzhou Foremed Legend Medical Technology Company, Ltd. (“Foremed Legend”) recently has announced the completion of pre-Series A+ funding.

Sep 01, 2023 02:53 PM

Briefing Nov 17, 2021 06:02 PM

Gilid signed an agreement with science and technology to deepen strategic cooperation in the areas of chronic hepatitis B, hepatitis C and HIV infection.

Briefing Sep 30, 2021 05:53 PM · Technology | Healthcare | Industrials

Gu Gang of HNA Group: 4 bankruptcy meeting processes of RMB 2 trillion declaration of creditor's rights have been successfully completed, waiting for the ruling

Briefing Aug 20, 2021 04:13 PM · Technology | Healthcare | Financials

Zhongyuan expressway: the net profit in the first half of the year was 642 million yuan, turning losses into profits year-on-year

Briefing Jul 29, 2021 10:01 AM

Back to Hong Kong, Chinese concept stocks rose collectively, and Wanguo data rose 17.5%

EqualOcean Analysis